Entering text into the input field will update the search result below

Aastrom Biosciences (ASTM) Downgraded to Neutral

Jan. 24, 2011 12:12 PM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

National Securities downgraded shares of Aastrom Biosciences (ASTM)  to a “NEUTRAL” rating in a research note to clients and investors.

ASTM had been ranked a “HOLD” in a report dated 1/14/11 from a “BUY” on 8/14/10.

  • Shares of Aastrom Biosciences (NASDAQ: ASTM) traded down 0.76% during trading on 1/21/11, closing at $2.59 but, with after-hours trading rose to $2.62;
  • ASTM has a 52 week low of $1.32 and a 52 week high of $2.96;
  • The stock’s 50-day moving average is $2.34 and its 200-day moving average is $1.73;
  • On average, analysts predict that ASTM will post (-$0.18) EPS in their quarterly (Q2/11) reporting;
  • ASTM has a market cap of $74.02 M with an enterprise value of $59.83M.

Referencing our blog, 1/20/11:

  • ASTM has closed DOWN 4 trading days (1/18-21/11) with high volumes (2.5M, 1.9M, 3.5M  and 1.4M).

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.